Literature DB >> 24712687

Spinal cord stimulation to achieve wound healing in a primary lower limb critical ischaemia referral centre.

Giovanni De Caridi1, Mafalda Massara1, Antonio David2, Massimiliano Giardina2, Michele La Spada1, Francesco Stilo1, Francesco Spinelli1, Raffaele Grande3, Lucia Butrico3, Stefano de Franciscis3,4, Raffaele Serra3,4.   

Abstract

Critical lower limb ischaemia is a diffuse pathology that could cause claudication, severe ischaemic pain and tissue loss. The common treatment includes modification of risk factors, pharmacological therapy and endovascular or surgical revascularisation of the lower limb to restore a pulsatile flow distally. Spinal cord stimulator is seen as a valid alternative in patients unsuitable for revascularisation after endovascular or surgical revascularisation failure and as adjuvant therapy in the presence of a functioning bypass in patients with extensive tissue loss and gangrene presenting a slow and difficult wound healing. We report our experience on spinal cord stimulation (SCS) indication and implantation in patients with critical lower limb ischaemia, at a high-volume centre for the treatment of peripheral arterial disease.
© 2014 The Authors. International Wound Journal © 2014 Medicalhelplines.com Inc and John Wiley & Sons Ltd.

Entities:  

Keywords:  Critical lower limb ischaemia; Pain relief; Spinal cord stimulation; Surgical revascularisation; Wound healing

Mesh:

Year:  2014        PMID: 24712687      PMCID: PMC7949687          DOI: 10.1111/iwj.12272

Source DB:  PubMed          Journal:  Int Wound J        ISSN: 1742-4801            Impact factor:   3.315


  27 in total

1.  Spinal cord stimulation in hemodialysis patients with critical lower-limb ischemia.

Authors:  Uwe Brümmer; Viviana Condini; Paolo Cappelli; Lorenzo Di Liberato; Michele Scesi; Mario Bonomini; Amedeo Costantini
Journal:  Am J Kidney Dis       Date:  2006-05       Impact factor: 8.860

2.  Application of platelet-rich gel to enhance healing of transmetatarsal amputations in diabetic dysvascular patients.

Authors:  Raffaele Serra; Gianluca Buffone; Andrea Dominijanni; Vincenzo Molinari; Rossella Montemurro; Stefano de Franciscis
Journal:  Int Wound J       Date:  2013-02-24       Impact factor: 3.315

Review 3.  The results of spinal cord stimulation in critical limb ischaemia: a review.

Authors:  G H Spincemaille; H C de Vet; D T Ubbink; M J Jacobs
Journal:  Eur J Vasc Endovasc Surg       Date:  2001-02       Impact factor: 7.069

Review 4.  Spinal cord stimulation for critical leg ischemia: a review of effectiveness and optimal patient selection.

Authors:  Dirk Th Ubbink; Hester Vermeulen
Journal:  J Pain Symptom Manage       Date:  2006-04       Impact factor: 3.612

Review 5.  Spinal cord stimulation for refractory angina pectoris and peripheral vascular disease.

Authors:  Timothy R Deer; Louis J Raso
Journal:  Pain Physician       Date:  2006-10       Impact factor: 4.965

6.  Spinal cord stimulation in peripheral vascular disease: a retrospective analysis of 95 cases.

Authors:  E Reig; D Abejón; C del Pozo; R Wojcikiewicz
Journal:  Pain Pract       Date:  2001-12       Impact factor: 3.183

Review 7.  Critical limb ischemia.

Authors:  Matthew J Blecha
Journal:  Surg Clin North Am       Date:  2013-08       Impact factor: 2.741

Review 8.  Managing chronic pain with spinal cord stimulation.

Authors:  Lawrence J Epstein; Marco Palmieri
Journal:  Mt Sinai J Med       Date:  2012 Jan-Feb

9.  Spinal cord stimulation.

Authors:  Milan P Stojanovic; Salahadin Abdi
Journal:  Pain Physician       Date:  2002-04       Impact factor: 4.965

10.  Spinal cord stimulation in critical limb ischemia of the lower extremities: our experience.

Authors:  I E Petrakis; V Sciacca
Journal:  J Neurosurg Sci       Date:  1999-12       Impact factor: 2.279

View more
  4 in total

1.  VAC therapy to promote wound healing after surgical revascularisation for critical lower limb ischaemia.

Authors:  Giovanni De Caridi; Mafalda Massara; Michele Greco; Narayana Pipitò; Francesco Spinelli; Raffaele Grande; Lucia Butrico; Stefano de Franciscis; Raffaele Serra
Journal:  Int Wound J       Date:  2014-05-28       Impact factor: 3.315

2.  Matrix metalloproteinases and risk stratification in patients undergoing surgical revascularisation for critical limb ischaemia.

Authors:  Giovanni De Caridi; Mafalda Massara; Francesco Spinelli; Antonio David; Sebastiano Gangemi; Francesco Fugetto; Raffaele Grande; Lucia Butrico; Roberta Stefanelli; Manuela Colosimo; Stefano de Franciscis; Raffaele Serra
Journal:  Int Wound J       Date:  2015-05-27       Impact factor: 3.315

3.  Local release of metalloproteinases and their inhibitors after a successful revascularisation procedure.

Authors:  Raffaele Grande; Gioia Brachini; Antonio V Sterpetti; Valeria Borrelli; Raffaele Serra; Francesco Pugliese; Giuseppe D'Ermo; Elvira Tartaglia; Paolo Rubino; Andrea Mingoli; Paolo Sapienza
Journal:  Int Wound J       Date:  2019-10-27       Impact factor: 3.315

4.  Impact of diabetes on outcome in critical limb ischemia with tissue loss: a large-scaled routine data analysis.

Authors:  Eva Freisinger; Nasser M Malyar; Holger Reinecke; Holger Lawall
Journal:  Cardiovasc Diabetol       Date:  2017-04-04       Impact factor: 9.951

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.